Resmed Inc. buy JPMorgan Chase & Co.
Start price
09.01.24
/
50%
€164.95
Target price
09.01.25
€178.27
Performance (%)
38.22%
End price
10.01.25
€228.00
Summary
This prediction ended on 10.01.25 with a price of €228.00. With a performance of 38.22% the BUY prediction by JPMorgan_Chase___Co_ was a big success. JPMorgan_Chase___Co_ has a follow-up prediction for Resmed Inc. where he still thinks Resmed Inc. is a Buy. A total of €1.87 was paid as dividends for this prediction. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Resmed Inc. | -7.251% | -7.251% | -1.846% |
| iShares Core DAX® | -1,10 % | -6,08 % | 0,87 % |
| iShares Nasdaq 100 | 0,33 % | 2,33 % | 18,26 % |
| iShares Nikkei 225® | -1,08 % | -7,99 % | 26,34 % |
| iShares S&P 500 | -0,06 % | 0,88 % | 13,29 % |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) had its price target raised by analysts at JPMorgan Chase & Co. from $160.00 to $195.00. They now have an "overweight" rating on the stock.
Ratings data for RMD provided by MarketBeat
In the thread Trading Resmed Inc.
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten